News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|May 1, 2008

New Product: Aerocrine's Niox Mino

The first FDA-approved device to measure airway inflammation in asthma patients.

Newly approved airway inflammation hand-held device

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older

FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older

ByMorgan Ebert, Executive Editor

July 24th 2026

US measles cases surpass 2025 total, hit highest level since 1991 | Image credit: © Prostock-studio - stock.adobe.com.

US measles cases surpass 2025 total, hit highest level since 1991

ByContemporary Pediatrics Staff

July 24th 2026

Pooled phase 3 data show early, consistent tapinarof cream responses across pediatric age groups in AD | Image credit: © Ruslan Ivantsov - stock.adobe.com.

Pooled phase 3 data show early, consistent tapinarof cream responses across pediatric age groups in AD

ByMorgan Ebert, Executive Editor

July 24th 2026

Prenatal therapy improves outcomes in fetal renal failure | Image credit: © guruXO - stock.adobe.com.X

Prenatal therapy improves outcomes in fetal renal failure

ByMorgan Ebert, Executive Editor

July 23rd 2026

Journal Club: Knee pain? Don’t forget SCFE!

Journal Club: Knee pain? Don’t forget SCFE!

ByMarian Freedman,Jon Matthew Farber, MD

July 23rd 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older

US measles cases surpass 2025 total, hit highest level since 1991

Pooled phase 3 data show early, consistent tapinarof cream responses across pediatric age groups in AD

Individualized gene therapy shows early promise for SCN2A-related epileptic encephalopathy

Prenatal therapy improves outcomes in fetal renal failure